| P | RR | 95% CI |
---|---|---|---|
Univariate | |||
 MCA cluster (negative vs. positive, n = 25 and 41) | 0.0016 | 2.4 | 1.4–4.1 |
 AR score | 0.35 | 0.9 | 0.8–1.1 |
 Prol. score | 0.039 | 1.1 | 1.0–1.1 |
 AR (ampl. vs. WT, n = 24 and 42) | 0.12 | 1.5 | 0.9–2.6 |
 Age (at metastsis surgery) | 0.42 | 1.0 | 1.0–1.0 |
 Metastasis subtype# | |||
  MetA (n = 46) |  | 1.0 |  |
  MetB (n = 12) | 0.034 | 2.0 | 1.1–3.9 |
  MetC (n = 8) | 0.95 | 0.98 | 0.45–2.1 |
 Serum PSA (at metastasis surgery) | 0.07 | 1.0 | 1.0–1.0 |
Multivariate | |||
 MCA cluster (negative vs. positive, n = 25 and 41) | 0.0017 | 2.7 | 1.5–5.1 |
 Prol. score | 0.89 | 0.99 | 0.90–1.1 |
 Metastasis subtype |  | 1.0 |  |
  MetA (n = 46) |  | 1.6 | 0.52–5.2 |
  MetB (n = 12) | 0.40 | 0.58 | 0.25–1.3 |
  MetC (n = 8) | 0.20 |  |  |